**About the Human Pharmaceuticals Business**
Boehringer Ingelheim's pharmaceutical research and development capabilities are globally leading in the industry. We continuously explore groundbreaking medical innovations and provide innovative drugs to meet patient needs in key therapeutic areas such as cardiovascular diseases, respiratory diseases, metabolic diseases, immunology, oncology, and central nervous system disorders. In the future, the company plans to launch innovative products or new indications of existing products in areas such as cardiovascular metabolism, respiratory, oncology, immunology, central nervous system, and retinal diseases to meet the needs of patients in China.

**About the China Center of Chemistry (CoC)**
The China Center of Chemistry (CoC) is a part of Boehringer Ingelheim's human pharmaceuticals organization, providing professional technical services to both internal and external customers of Boehringer Ingelheim:1) Offering technical support...